Bile Acid Binder to Lower PFAS Chemicals in Veterans
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a medication called colesevelam can help remove harmful PFAS chemicals (forever chemicals found in drinking water and food) from your body. PFAS accumulate over time and may affect health, and this trial explores whether this bile acid binder can safely reduce your levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a Veteran (military service background) aged 25–65
- Blood test shows PFAS level above 20 ng/ml (exceeding safe guidance)
- Able to give written informed consent and sign privacy authorization
- Can attend outpatient visits and complete the study
- Not pregnant, nursing, or planning pregnancy during the study
- Willing to allow your data and biological samples to be stored for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking a special tablet twice daily can help male firefighters lower PFAS chemicals in their bodies. It involves three visits in the San Francisco Bay Area, at-home blood tests, and weekly text surveys over about 6.5 months.
This study looks at using a genetic test to help doctors choose the best statin medicine for veterans who need to lower their cholesterol but haven't taken a statin in the last 6 months. If you have diabetes, heart disease, or have had a stroke, this trial may help find a statin that works well for you with fewer side effects.
This study tests whether cholestyramine can lower blood levels of certain stored environmental pollutants (“POPs”) in women preparing for weight-loss surgery. If it works, it may help reduce pollutant levels that can build up in the body over time.
This study tests fenofibrate, a medicine that may help lower liver enzymes in people with primary biliary cholangitis (PBC). It looks at how well the drug works in everyday medical practice.
This trial is testing whether adding fenofibrate to the standard PBC medicine ursodeoxycholic acid helps people with primary biliary cholangitis. It's a real-world study, meaning it looks at how treatments work in everyday practice. You can join only if you have already completed an earlier fenofibrate study.
This is an early-stage study testing a new medicine called PF-08653944 in healthy adults and in people with varying degrees of liver function problems. The goal is to understand how the medicine works in the body and how liver function affects how the body processes it.
Hear when a new Burn Pit Exposure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.